News

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component of this system are pattern recognition receptors, which recognize non-self ...
HHS Sec. RFK Jr. says Dr. Anthony Fauci is likely liable for the origins of the COVID-19 pandemic, calling for a nationwide ...
Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to ...
Key Takeaways Moderna’s mRNA flu vaccine worked better than the standard flu shot in a new trialIt showed 26.6% better ...
This news roundup covers significant developments in the health industry, including France's Carmat filing for insolvency, ...
Astonishing claims have emerged from recent studies suggesting a chilling surge in cancer rates, particularly among women, reportedly linked to climate change. However, the narrative being pushed by ...
The most read stories this past month detailed the passing of Dimitrios Karmpaliotis and news on Evoque and COVID-19.
The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review standards.
RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...
Moderna's mRNA flu vaccine showed 26.6% better efficacy than a standard flu shot in adults 50 and older during a global Phase ...
In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...